[The effect of a Rhodiola rosea extract on the incidence of recurrences of a superficial bladder cancer (experimental clinical research)].
Oral administration of Rhodiola rosea extract to a small group of patents (n = 12) with superficial bladder carcinoma (T1G1-2) improved the characteristics of the urothelial tissue integration, parameters of leukocyte integrins and T-cell immunity. The average frequency of relapses for these patients has been found to fall twice, though statistical differences were not significant.
Bocharova
O A
OA
Matveev
B P
BP
Baryshnikov
A Iu
AIu
Figurin
K M
KM
Serebriakova
R V
RV
Bodrova
N B
NB
D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000453:epidemiology / Q000276:immunology / Q000473:pathology; D004341:Drug Evaluation; D006801:Humans; D007109:Immunity / Q000187:drug effects; D015994:Incidence; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy* / Q000453:epidemiology / Q000276:immunology / Q000473:pathology; D010936:Plant Extracts / Q000627:therapeutic use*; D013997:Time Factors; D001743:Urinary Bladder / Q000187:drug effects / Q000473:pathology; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000453:epidemiology / Q000276:immunology / Q000473:pathology
D010936:Plant Extracts
Vliianie ékstrakta Rhodiola rosea na chastotu retsidivov poverkhnostnogo raka mochevogo puzyria (éksperimental'no-klinicheskoe issledovanie).